COVID-19 Vaccine (Moderna) - Revision history

Rossdonaldson1: Reverted edits by Rossdonaldson1 (talk) to last revision by Jmf300

2022-01-18T22:52:28Z

Reverted edits by Rossdonaldson1 (talk) to last revision by Jmf300

← Older revision		Revision as of 22:52, 18 January 2022
Line 1:		Line 1:
	~~#REDIRECT~~[[~~COVID~~-19]]		==Background==
			The Moderna COVID-19 vaccine is an mRNA based vaccine which is approved in the United States to prevent symptomatic COVID-19 infection. The Moderna vaccine was the second COVID-19 vaccine to be approved for distribution in the United States, and it was granted Emergency Use Authorization by the United States Food and Drug Administration (FDA) on 18 December 2020.

			The approved dosing regimen is two doses, 100 μg each, administered 28 days apart. The vaccine is approved for individuals 18 years of age and older.

			The vaccine is intended to prevent the COVID-19 illness, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Moderna vaccine targets the SARS-CoV-2 spike glycoprotein (S).

			==Clinical Features==

			==Administration==
			*Type: SARS-CoV-2 spike glycoprotein (S) antigen encoded by RNA and formulated in lipid nanoparticles (LNPs).
			*Dosage Forms: 2 doses of 100 μg each, administered 28 days apart.
			*Routes of Administration: Intramuscular
			*Common Trade Names: Moderna COVID-19 Vaccine, Moderna Vaccine

			==Adult Dosing==


			==Pediatric Dosing==


			==Special Populations==
			===[[Drug pregnancy categories\|Pregnancy Rating]]===
			*

			===Lactation risk===
			*

			===Renal Dosing===
			*Adult:
			*Pediatric:

			===Hepatic Dosing===
			*Adult:
			*Pediatric:

			==Contraindications==
			*Allergy to class/drug

			==Adverse Reactions==
			===Serious===


			===Common===


			==Pharmacology==
			*Half-life:
			*Metabolism:
			*Excretion:

			==Mechanism of Action==


			==Comments==


			==See Also==

			==External Links==

			==References==
			<references/>

			[[Category:Pharmacology]]

Rossdonaldson1: Redirected page to COVID-19

2022-01-18T21:08:05Z

Redirected page to COVID-19

← Older revision		Revision as of 21:08, 18 January 2022
Line 1:		Line 1:
	~~==Background==~~		#REDIRECT[[COVID-19]]
	The Moderna COVID-19 vaccine is an mRNA based vaccine which is approved in the United States to prevent symptomatic COVID-19 infection. The Moderna vaccine was the second COVID-19 vaccine to be approved for distribution in the United States, and it was granted Emergency Use Authorization by the United States Food and Drug Administration (FDA) on 18 December 2020.

	~~The approved dosing regimen is two doses, 100 μg each, administered 28 days apart. The vaccine is approved for individuals 18 years of age and older.~~

	The vaccine is intended to prevent the COVID-19 illness, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Moderna vaccine targets the SARS-CoV-2 spike glycoprotein (S).

	~~==Clinical Features==~~

	~~==Administration==~~
	*Type: SARS-CoV-2 spike glycoprotein (S) antigen encoded by RNA and formulated in lipid nanoparticles (LNPs).
	*Dosage Forms: 2 doses of 100 μg each, administered 28 days apart.
	*Routes of Administration: Intramuscular
	*Common Trade Names: Moderna COVID-19 Vaccine, Moderna Vaccine

	~~==Adult Dosing==~~


	~~==Pediatric Dosing==~~


	~~==Special Populations==~~
	~~===~~[[~~Drug pregnancy categories\|Pregnancy Rating]]===~~
	*

	~~===Lactation risk===~~
	*

	~~===Renal Dosing===~~
	*Adult:
	*Pediatric:

	~~===Hepatic Dosing===~~
	*Adult:
	*Pediatric:

	~~==Contraindications==~~
	*Allergy to class/drug

	~~==Adverse Reactions==~~
	~~===Serious===~~


	~~===Common===~~


	~~==Pharmacology==~~
	*Half-life:
	*Metabolism:
	*Excretion:

	~~==Mechanism of Action==~~


	~~==Comments==~~


	~~==See Also==~~
	~~{{Special:Prefixindex/COVID-19 \|hideredirects=1}}~~

	~~==External Links==~~

	~~==References==~~
	~~<references/>~~

	~~[[Category:Pharmacology]]~~

	~~[[Category:~~COVID-19]]

Rossdonaldson1: /* See Also */

2021-01-16T09:20:23Z

Rossdonaldson1: /* References */

2021-01-16T09:18:38Z

References

← Older revision		Revision as of 09:18, 16 January 2021
Line 64:		Line 64:

	[[Category:Pharmacology]]		[[Category:Pharmacology]]

			[[Category:COVID-19]]

Jmf300 at 04:05, 21 December 2020

2020-12-21T04:05:09Z

← Older revision		Revision as of 04:05, 21 December 2020
Line 8:		Line 8:
	==Clinical Features==		==Clinical Features==

			==Administration==

	*Type: SARS-CoV-2 spike glycoprotein (S) antigen encoded by RNA and formulated in lipid nanoparticles (LNPs).		*Type: SARS-CoV-2 spike glycoprotein (S) antigen encoded by RNA and formulated in lipid nanoparticles (LNPs).
	*Dosage Forms: 2 doses of 100 μg each, administered 28 days apart.		*Dosage Forms: 2 doses of 100 μg each, administered 28 days apart.

Jmf300: /* Background */

2020-12-21T04:04:05Z

Background

← Older revision		Revision as of 04:04, 21 December 2020
Line 1:		Line 1:
	==Background==		==Background==
	The Moderna COVID-19 vaccine is an mRNA based vaccine which is approved in the United States to prevent symptomatic COVID-19 infection. The Moderna vaccine was the second COVID-19 vaccine to be approved for distribution in the United States, and it was granted Emergency Use Authorization by the United States Food and Drug Administration on 18 December 2020.		The Moderna COVID-19 vaccine is an mRNA based vaccine which is approved in the United States to prevent symptomatic COVID-19 infection. The Moderna vaccine was the second COVID-19 vaccine to be approved for distribution in the United States, and it was granted Emergency Use Authorization by the United States Food and Drug Administration (FDA) on 18 December 2020.

	The approved dosing regimen is two doses, 100 μg each, administered 28 days apart. The vaccine is approved for individuals 18 years of age and older.		The approved dosing regimen is two doses, 100 μg each, administered 28 days apart. The vaccine is approved for individuals 18 years of age and older.

Jmf300: /* Administration */

2020-12-21T03:48:45Z

Administration

← Older revision		Revision as of 03:48, 21 December 2020
Line 10:		Line 10:


	~~==Administration==~~		*Type: SARS-CoV-2 spike glycoprotein (S) antigen encoded by RNA and formulated in lipid nanoparticles (LNPs).
	*Type:		*Dosage Forms: 2 doses of 100 μg each, administered 28 days apart.
	*Dosage Forms:		*Routes of Administration: Intramuscular
	*Routes of Administration:		*Common Trade Names: Moderna COVID-19 Vaccine, Moderna Vaccine
	*Common Trade Names:

	==Adult Dosing==		==Adult Dosing==

Jmf300: /* Background */

2020-12-21T03:47:18Z

Background

← Older revision		Revision as of 03:47, 21 December 2020
Line 1:		Line 1:
	==Background==		==Background==
			The Moderna COVID-19 vaccine is an mRNA based vaccine which is approved in the United States to prevent symptomatic COVID-19 infection. The Moderna vaccine was the second COVID-19 vaccine to be approved for distribution in the United States, and it was granted Emergency Use Authorization by the United States Food and Drug Administration on 18 December 2020.

			The approved dosing regimen is two doses, 100 μg each, administered 28 days apart. The vaccine is approved for individuals 18 years of age and older.

			The vaccine is intended to prevent the COVID-19 illness, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Moderna vaccine targets the SARS-CoV-2 spike glycoprotein (S).

	==Clinical Features==		==Clinical Features==

Jmf300: Created page with "==Background== ==Clinical Features== ==Administration== Type: Dosage Forms: Routes of Administration: Common Trade Names: ==Adult Dosing== ==Pediatric Dosing==..."

2020-12-21T03:29:31Z

Created page with "==Background== ==Clinical Features== ==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing==..."

New page

==Background==

==Clinical Features==

==Administration==
*Type:
*Dosage Forms:
*Routes of Administration:
*Common Trade Names:

==Adult Dosing==

==Pediatric Dosing==

==Special Populations==
===[[Drug pregnancy categories|Pregnancy Rating]]===
*

===Lactation risk===
*

===Renal Dosing===
*Adult:
*Pediatric:

===Hepatic Dosing===
*Adult:
*Pediatric:

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===

===Common===

==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:

==Mechanism of Action==

==Comments==

==See Also==

==External Links==

==References==
<references/>

[[Category:Pharmacology]]

← Older revision		Revision as of 09:20, 16 January 2021
Line 57:		Line 57:

	==See Also==		==See Also==
			{{Special:Prefixindex/COVID-19 \|hideredirects=1}}

	==External Links==		==External Links==

COVID-19 Vaccine (Moderna) - Revision history

Rossdonaldson1: Reverted edits by Rossdonaldson1 (talk) to last revision by Jmf300

Rossdonaldson1: Redirected page to COVID-19

Rossdonaldson1: /* See Also */

Rossdonaldson1: /* References */

Jmf300 at 04:05, 21 December 2020

Jmf300: /* Background */

Jmf300: /* Administration */

Jmf300: /* Background */

Jmf300: Created page with "==Background== ==Clinical Features== ==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing==..."

Jmf300: Created page with "==Background== ==Clinical Features== ==Administration== Type: Dosage Forms: Routes of Administration: Common Trade Names: ==Adult Dosing== ==Pediatric Dosing==..."